Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery

被引:13
|
作者
Tang, Yisi [1 ,2 ,3 ,4 ]
Liu, Bao [1 ,2 ]
Zhang, Yuting [1 ,2 ]
Liu, Yuling [1 ,2 ]
Huang, Yongzhuo [1 ,5 ,6 ,7 ]
Fan, Wufa [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel Form, Beijing 100050, Peoples R China
[3] Chinese Acad Med Sci, Inst Lab Anim Sci, NHC Key Lab Comparat Med, Natl Ctr Technol Innovat Anim Model, Beijing 100021, Peoples R China
[4] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[6] Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China
[7] NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipie, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Lymphatic system; Lymphatic delivery system; Lymph node; Protein corona; Dendritic cell; Vaccine; LIPID-BASED FORMULATIONS; DENDRITIC CELLS; SUBCUTANEOUS INJECTION; ORAL DELIVERY; TRANSPORT; NODE; ACID; ABSORPTION; LIPOSOMES; EXPOSURE;
D O I
10.1016/j.addr.2024.115304
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lymphatic system has garnered significant attention in drug delivery research due to the advantages it offers, such as enhancing systemic exposure and enabling lymph node targeting for nanomedicines via the lymphatic delivery route. The journey of drug carriers involves transport from the administration site to the lymphatic vessels, traversing the lymph before entering the bloodstream or targeting specific lymph nodes. However, the anatomical and physiological barriers of the lymphatic system play a pivotal role in influencing the behavior and efficiency of carriers. To expedite research and subsequent clinical translation, this review begins by introducing the composition and classification of the lymphatic system. Subsequently, we explore the routes and mechanisms through which nanoparticles enter lymphatic vessels and lymph nodes. The review further delves into the interactions between nanomedicine and body fluids at the administration site or within lymphatic vessels. Finally, we provide a comprehensive overview of recent advancements in lymphatic delivery systems, addressing the challenges and opportunities inherent in current systems for delivering macromolecules and vaccines.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Nanoparticles in Ocular Drug Delivery Systems
    Almeida, Hugo
    Silva, Ana Catarina
    PHARMACEUTICS, 2023, 15 (06)
  • [32] Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment
    Reis, Catarina Pinto
    Martinho, Nuno
    Rosado, Catarina
    Fernandes, Ana S.
    Roberto, Amilcar
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (03) : 409 - 417
  • [33] Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems
    Maeki, Masatoshi
    Kimura, Niko
    Sato, Yusuke
    Harashima, Hideyoshi
    Tokeshi, Manabu
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 128 : 84 - 100
  • [34] Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review
    Graham, Willem
    Torbett-Dougherty, Mckayla
    Islam, Akm
    Soleimani, Shokoufeh
    Bruce-Tagoe, Tracy Ann
    Johnson, Jacqueline Ann
    NANOMATERIALS, 2025, 15 (04)
  • [35] Development and Evaluation of Silver Nanoparticles and its Applications in Topical Drug Delivery Systems
    Bhagat, Sonali Arjunrao
    Singh, Meera Chandradatt
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (01) : 16 - 21
  • [36] INTERACTIONS BETWEEN POLYMERIC DRUG DELIVERY SYSTEMS AND BIOLOGICAL-SYSTEMS - BARRIERS AND OPPORTUNITIES
    HIMMELSTEIN, KJ
    ACS SYMPOSIUM SERIES, 1991, 469 : 34 - 41
  • [37] Biodegradable PLGA Based Nanoparticles for Sustained Regional Lymphatic Drug Delivery
    Rao, Deepa A.
    Forrest, M. Laird
    Alani, Adam W. G.
    Kwon, Glen S.
    Robinson, Joseph R.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (04) : 2018 - 2031
  • [38] Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
    Cai, Shuang
    Yang, Qiuhong
    Bagby, Taryn R.
    Forrest, M. Laird
    ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (10-11) : 901 - 908
  • [39] Nanoporous silicon nanoparticles for drug delivery applications
    Donnorso, M. Perrone
    Miele, E.
    De Angelis, F.
    La Rocca, R.
    Limongi, T.
    Zanacchi, F. Cella
    Marras, S.
    Brescia, R.
    Di Fabrizio, E.
    MICROELECTRONIC ENGINEERING, 2012, 98 : 626 - 629
  • [40] Engineered Inorganic Nanoparticles for Drug Delivery Applications
    Ojea-Jimenez, Isaac
    Comenge, Joan
    Garcia-Fernandez, Lorena
    Megson, Zoe A.
    Casals, Eudald
    Puntes, Victor F.
    CURRENT DRUG METABOLISM, 2013, 14 (05) : 518 - 530